Head-to-head · WeighScore
ElixaMD vs NuuVim
The verdict
NuuVim takes it — 70.6/100 to 63.7/100.
NuuVim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | ElixaMD | NuuVim |
|---|---|---|
| WeighScore | 63.7/100 | 70.6/100 |
| Grade | C | C |
| Site position | #280 | #114 |
| Semaglutide | $99/mo (first month; $199/mo refills, compounded) | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide | Zepbound: $99 membership + medication (total not disclosed) | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #280 · C
Strengths
- Compounded semaglutide offer states $99 for the first month and $199 for refills, including medication and shipping
- Advertises a care portal, physician guidance and ongoing support
- Names Triad Rx, RedRock Pharmacy and Beaker Pharmacy & Compounding
- Advertises Wegovy pill, Wegovy injection and Zepbound options with a separate membership charge
Where it loses points
- Branded medication costs are additional to the $99 membership; injection availability is qualified
- Free dietitian visits depend on insurance and copay eligibility at the visit
- Cancellation requires at least 72 hours before renewal; refund provisions have conditions
- A complete public state-availability list was not established in this review
Site position #114 · C
Strengths
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
Where it loses points
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
- The site's own llms.txt advertises pricing, FAQ and terms files that all 404
- No state count is published
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.